RMFEX | TRCVX | RMFEX / TRCVX | |
Total Expense Ratio | 0.62 | 0.30 | 207% |
Annual Report Gross Expense Ratio | 0.62 | 0.30 | 207% |
Fund Existence | 23 years | 23 years | - |
Gain YTD | 13.941 | 10.929 | 128% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 111B | 11.4B | 974% |
Annual Yield % from dividends | 1.46 | 1.52 | 96% |
Returns for 1 year | 5.28 | 5.75 | 92% |
Returns for 3 years | 40.09 | 39.85 | 101% |
Returns for 5 years | 59.52 | 64.70 | 92% |
Returns for 10 years | 98.84 | 87.05 | 114% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RSMR | 21.44 | 0.09 | +0.40% |
FT Vest U.S. Equity Equal Weight Buffer ETF - March | |||
JPI | 20.68 | N/A | N/A |
Nuveen Preferred Securities & Income Opportunities Fund | |||
NPFI | 26.39 | N/A | -0.02% |
Nuveen Preferred and Income ETF | |||
WDNA | 17.32 | -0.23 | -1.34% |
WisdomTree BioRevolution ETF | |||
ARKG | 31.00 | -1.08 | -3.37% |
ARK Genomic Revolution ETF |